Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Emerging Ethical Challenges Raised by the Evolution of Vascularized Composite Allotransplantation

Caplan, Arthur L., PhD1; Parent, Brendan, PD1; Kahn, Jeffrey, PhD2; Dean, Wendy, MD3; Kimberly, Laura L., MSW1,4; Lee, W.P, Andrew, MD5; Rodriguez, Eduardo D., MD4

doi: 10.1097/TP.0000000000002478
Original Clinical Science—General
Buy

Background. Despite early skepticism, the field of vascularized composite allotransplantation (VCA) has demonstrated feasibility. The ethics of VCA have moved past doubts about the morality of attempting such transplants to how to conduct them ethically.

Methods. Leaders of each program performing and/or evaluating VCA in the United States were invited to participate in a working group to assess the state and future of VCA ethics and policy. Four meetings were held over the course of 1 year to describe key challenges and potential solutions.

Results. Working group participants concluded that VCA holds great promise as treatment for patients with particular injuries or deficits, but the field faces unique challenges to adoption as standard of care, which can only be overcome by data sharing and standardization of evaluation and outcome metrics.

Conclusions. Adequate attention must be given to concerns including managing the uniquely intense physician-patient relationship, ethical patient selection, ensuring patients have adequate representation, informing and earning the trust of the public for donation, standardizing metrics for success, and fostering an environment of data sharing. These steps are critical to transitioning VCA from research to standard of care and to its insurance coverage inclusion.

1 Division of Medical Ethics, NYU School of Medicine, New York, NY.

2 Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD.

3 Strategic Initiatives, Henry Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD.

4 Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, NY.

5 Department of Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Received 30 May 2018. Revision received 27 September 2018.

Accepted 29 September 2018.

The authors declare no conflicts of interests.

Working group hosts received a gift from United Therapeutics to support travel and lodging for participants of working group meetings.

List of members/contributors to NYU/Hopkins VCA ethics working group: Arthur L. Caplan, Jeffrey Kahn, Brendan Parent, WP Andrew Lee, Wendy Dean, Laura L. Kimberly, Bruce Gelb, James F. Childress, Eduardo D. Rodriguez, James McCartney, Nomi Levy-Carrick, Gerard MaGill, Hatem Amer, Rolph N Barth, Leslie Bernstein, Rosamond Rhodes, David B. Sarwer, Helen Irving, Simon Talbot, Kevin I. Reid, Elisa J. Gordon, Benjamin Chang, Lisa Kearns, James Benedict, Linda C. Cendales, Jeremy Sugarman, and the NYU/Johns Hopkins Working group on Ethics and VCA*.

All authors participated in working group meetings and drafting documents on assigned relevant topics. B.P. wrote the initial draft of this article based on literature review, notes from working group meetings, and content in assigned documents. A.C. revised with significant feedback from L.K., J.K., W.D., and B.G. W.P.A.L. and E.D.R. contributed to design and final revisions.

Correspondence: Brendan Parent, JD, Suite 825b, 7 East 12th St, New York, NY 10003. (brendan.parent@nyu.edu).

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.